Novel AI-Designed USP1 Inhibitor Receives IND Approval (IMAGE)

InSilico Medicine

Novel AI-Designed USP1 Inhibitor Receives IND Approval

Caption

Insilico expects to first initiate the study in the U.S. center in July 2023.

Credit

Insilico Medicine

Usage Restrictions

none

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.